← Eichor
Condition: Herpes Zoster Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Herpes Zoster

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
NA · 1 location(s) · Beijing Tiantan Hospital · NCT07307170Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Effect of MTX Discontinuation on Shingrix Response in RA
NA · 1 location(s) · Konkuk University Medical Center · NCT06574594Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
Phase 1/Phase 2 · 1 location(s) · Sinovac Biotech Co., Ltd · NCT07400003Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Phase 2 · 1 location(s) · Loyola University · NCT05554068Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic Neuralgia
NA · 1 location(s) · Mohamed Hosny Ismail Easa · NCT07123987A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rub
Phase 3 · 22 location(s) · GlaxoSmithKline · NCT06855160A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
Phase 1/Phase 2 · 1 location(s) · Shanghai Institute Of Biological Products · NCT06932523The Analgesic Efficacy and Safety of Baclofen in Patients With Herpes Zoster
NA · 1 location(s) · Beijing Tiantan Hospital · NCT07378046Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zo
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07534007Second Dose of Varicella Vaccine in Healthy Children
Phase 3 · 5 location(s) · Sinovac (Dalian) Vaccine Technology Co., Ltd. · NCT07475000Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07321808A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine,
Phase 3 · 17 location(s) · GlaxoSmithKline · NCT07406360The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster
NA · 1 location(s) · Beijing Tiantan Hospital · NCT07370389Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients
NA · 1 location(s) · Central Adelaide Local Health Network Incorporated · NCT06262776Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia
NA · 1 location(s) · Beijing Tiantan Hospital · NCT06890897Subcutaneous Calcitonin in Acute Herpes Zoster
Phase 3 · 1 location(s) · Tanta University · NCT07655804High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoste
Phase 4 · 1 location(s) · Shirong Tan · NCT06959147A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine
Phase 3 · 1 location(s) · Beijing Luzhu Biotechnology Co., Ltd. · NCT06088745A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Heal
Phase 3 · 6 location(s) · GlaxoSmithKline · NCT06806137A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Chil
Phase 3 · 1 location(s) · GC Biopharma Corp · NCT07054099A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to
Phase 3 · 97 location(s) · GlaxoSmithKline · NCT06740630Electroacupuncture Regulation of Immune Cells in Herpes Zoster
NA · 1 location(s) · First People's Hospital of Hangzhou · NCT06643247Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?
Phase N/A · 1 location(s) · University of Alberta · NCT05923970A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population A
Phase 4 · 8 location(s) · GlaxoSmithKline · NCT07502560Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation
NA · 1 location(s) · Dexiong Han · NCT07515885A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Phase 3 · 46 location(s) · GlaxoSmithKline · NCT06693895Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy
NA · 1 location(s) · University of British Columbia · NCT05424302A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular D
Phase N/A · 2 location(s) · Center for Clinical Studies, Texas · NCT06903078Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia
Phase 4 · 2 location(s) · Tor Biering-Sørensen · NCT07485283
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.